immunosuppressive drugs segments hold a larger share in the market than other classes due to
their proven efficacy in reducing symptoms and wider use in SLE conditions with organ
complication. Biologics drugs segment are slowly gaining traction in the market with better
outcomes and more patient compliance. Guidelines for use of biologic are also boosting
confidence among physicians for adoption of biologics, as treatment for systemic lupus
erythematosus.
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering action-
ready syndicated research reports, custom market analysis, consulting services, and competitive
analysis through various recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com